Maria A Papadaki - Search Results

Year	Number of Results
2009	1
2011	1
2013	1
2014	1
2015	2
2018	1
2019	1
2020	4
2021	3
2022	4
2024	1

1

Single-Cell RNA Sequencing Uncovers Heterogeneous Circulating Tumor Cell Subsets in Breast Cancer.

Papadaki MA, Agelaki S. Papadaki MA, et al. Cancers (Basel). 2022 Mar 4;14(5):1314. doi: 10.3390/cancers14051314. Cancers (Basel). 2022. PMID: 35267622 Free PMC article.

2

Plasma-Based microRNA Expression Analysis in Advanced Stage NSCLC Patients Treated with Nivolumab.

Monastirioti A, Papadaki C, Kalapanida D, Rounis K, Michaelidou K, Papadaki MA, Mavroudis D, Agelaki S. Monastirioti A, et al. Among authors: papadaki ma. Cancers (Basel). 2022 Sep 28;14(19):4739. doi: 10.3390/cancers14194739. Cancers (Basel). 2022. PMID: 36230658 Free PMC article.

3

Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer.

Papadaki MA, Koutsopoulos AV, Tsoulfas PG, Lagoudaki E, Aggouraki D, Monastirioti A, Koutoulaki C, Apostolopoulou CA, Merodoulaki AC, Papadaki C, Mavroudis D, Agelaki S. Papadaki MA, et al. Cancers (Basel). 2020 Feb 6;12(2):376. doi: 10.3390/cancers12020376. Cancers (Basel). 2020. PMID: 32041353 Free PMC article.

4

Investigating the Role of CTCs with Stem/EMT-like Features in Metastatic Breast Cancer Patients Treated with Eribulin Mesylate.

Papadaki MA, Mala A, Merodoulaki AC, Vassilakopoulou M, Mavroudis D, Agelaki S. Papadaki MA, et al. Cancers (Basel). 2022 Aug 12;14(16):3903. doi: 10.3390/cancers14163903. Cancers (Basel). 2022. PMID: 36010896 Free PMC article.

5

Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients.

Papadaki MA, Aggouraki D, Vetsika EK, Xenidis N, Kallergi G, Kotsakis A, Georgoulias V. Papadaki MA, et al. Anticancer Res. 2021 Feb;41(2):661-670. doi: 10.21873/anticanres.14817. Anticancer Res. 2021. PMID: 33517270

6

TLR4 and pSTAT3 Expression on Circulating Tumor Cells (CTCs) and Immune Cells in the Peripheral Blood of Breast Cancer Patients: Prognostic Implications.

Papadaki MA, Monastirioti A, Apostolopoulou CA, Aggouraki D, Papadaki C, Michaelidou K, Vassilakopoulou M, Alexakou K, Mavroudis D, Agelaki S. Papadaki MA, et al. Cancers (Basel). 2022 Feb 18;14(4):1053. doi: 10.3390/cancers14041053. Cancers (Basel). 2022. PMID: 35205801 Free PMC article.

7

MicroRNAs Regulating Tumor and Immune Cell Interactions in the Prediction of Relapse in Early Stage Breast Cancer.

Papadaki C, Thomopoulou K, Monastirioti A, Koronakis G, Papadaki MA, Rounis K, Vamvakas L, Nikolaou C, Mavroudis D, Agelaki S. Papadaki C, et al. Among authors: papadaki ma. Biomedicines. 2021 Apr 13;9(4):421. doi: 10.3390/biomedicines9040421. Biomedicines. 2021. PMID: 33924670 Free PMC article.

8

Apoptotic circulating tumor cells in early and metastatic breast cancer patients.

Kallergi G, Konstantinidis G, Markomanolaki H, Papadaki MA, Mavroudis D, Stournaras C, Georgoulias V, Agelaki S. Kallergi G, et al. Among authors: papadaki ma. Mol Cancer Ther. 2013 Sep;12(9):1886-95. doi: 10.1158/1535-7163.MCT-12-1167. Epub 2013 Jun 18. Mol Cancer Ther. 2013. PMID: 23778153

9

Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer.

Agelaki S, Kalykaki A, Markomanolaki H, Papadaki MA, Kallergi G, Hatzidaki D, Kalbakis K, Mavroudis D, Georgoulias V. Agelaki S, et al. Among authors: papadaki ma. PLoS One. 2015 Jun 17;10(6):e0123683. doi: 10.1371/journal.pone.0123683. eCollection 2015. PLoS One. 2015. PMID: 26083256 Free PMC article. Clinical Trial.

10

Rapid and reliable testing for clinically actionable EGFR mutations in non-small cell lung cancer using the Idylla^TM platform: a real-world two-center experience in Greece.

Michaelidou K, Karniadakis I, Pantelaion V, Koutoulaki C, Boukla E, Folinas K, Dimaras P, Papadaki MA, Koutsopoulos AV, Mavroudis D, Vourlakou C, Mavridis K, Agelaki S. Michaelidou K, et al. Among authors: papadaki ma. Expert Rev Mol Diagn. 2024 Jan-Feb;24(1-2):89-98. doi: 10.1080/14737159.2024.2303320. Epub 2024 Jan 11. Expert Rev Mol Diagn. 2024. PMID: 38193169

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

19 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year